Page 705 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux
P. 705

666                   MÉDICAMENTS EN RELA T1ON A VEC DES SYSTÈMES HORMONA UX

           JOHNSON R.L., CAREY S.C., NORMAN A.W., OKAMURA W.H. J. Med. Chem., 1977,
             20, 5 in IKEKAWA N. Structures and biological activities of vitamin D métabolites
             and their analogs, Médicinal Research Reviews 1987, 7, 348.
           NORMAN A.W., JOHNSON R.L., CORRADINO R., OKAMURA W.H. Structure-function
             studies of the side Chain of 25-hydroxyvitamin D3, J. Biol. Chem. 1979, 254, 1145­
              1149.
            NAPOLI J.L., MELLON W.S., FIVIZZANI M.A., SCHNOES H.K., DELUCA H.F.
             Synthesis and biological activity of 24-hydroxy-25-fluorovitamin D3. A highly potent
              mediator of calcium metabolism. J. Biol. Chem. 1979, 254, 2017-2022.
            KOEFFLER H.P., AMATRUDA T., IKEKAWA N., KOYABASHI Y., DELUCA H.F. Cancer
              Research, 1984, 44, 5624, in IKEKAWA N. Structures and biological activities of
              vitamin D métabolites and their analogs, Médicinal Reserach Reviews 1987, 7, 357.
            EDELSTEIN S., SHEVES M., MAZUR Y., BAR A., HURWITZ S. Synthesis and biologi­
              cal action of 3-deoxy-vitamin D3 and 3-deoxy-25-hydroxyvitamin D3. FEBS Letters,
              1979,97, 241-244.
            ONISKO B.L., SCHNOES H.K., DELUCA H.F. Tetrahedron Lett., 1977, 13, 1107 et J.
              Biol Chem. 1979, 254, 3493, in IKEKAWA N. Structures and biological activities of
              vitamine D métabolites and their analogs, Médicinal Research Reviews 1987, 7,
              357-358.
            NORMAN A.W., HAMMOND M.L., OKAMURA W.H. 19-hydroxy-10S (19)-dihydrovita-
              min D3 II : an analog of vitamin D3 wich possesses “anti-vitamin" activity, Fed.
              Proc. 1977, 36, 914.
            DOLLERY C. (edit) Calciferol in Dictionary of drugs, Churchill-Livingston. Edinburgh
              1991 (vol1), C13-C17.
            DOLLERY C. (edit) Calcifediol in Dictionnary of drugs, Churchill-Livingston. Edinburgh
              1991 (vol 1), C8-C13.
             DOLLERY C. (edit) Calcitriol in Dictionnary of drugs. Churchill-Livingston. Edinburgh
               1991 (vol 1), C22-C27.
             DOLLERY C. (edit) Alfacalcidol in Dictionnary of drugs. Churchill-Livingston.
               Edinburgh 1991 (vol 1), A37-A42.
             DOLLERY C. (edit) Calcipotriol in Dictionnary of drugs. Churchill-Livingston. Edinburgh
               1992 (vol 1), 40-2.
             SEINO Y., ISHIZUKA S. 23(S),25(R)-1a,25-(OH)2-D3-26,23-lacton, Drugs of the future
               1992, 17, (8), 655-659.
             HAMADA K., SHINOMIYA H. Novel vitamin D3 and their potential for inhibiting cancer
               cell growth, Drugs ofthe future 1993,18, 1057-1061.
             JONES G., CALVERLEY M.J. Newer vitamin D Drugs for use in bone disease, psoria­
               sis and cancer, TEM 1993, 4, 297-303.

             Activités
             FOURNIER A., GARABEDIAN M., SEBERT J.C., MEUNIER P.J. Vitamine D et maladie
              des os et du métabolisme minéral. Masson Edit, Paris, New York, 1984.
             MORIMOTO S., YOSHIKAWA K. Psoriasis and vitamin D3. A review of our expérience.
              Archiv. Dermatol., 1989, 125, 231-234.
   700   701   702   703   704   705   706   707   708   709   710